Movano health commences clinical study with new cuffless blood pressure device

New proprietary rf hardware delivers significantly enhanced signal fidelity pleasanton, calif. , feb. 4, 2025 /prnewswire/ -- movano health (nasdaq: move) announced today that it has commenced a blood pressure clinical trial with its newly developed cuffless blood pressure wrist wearable.

MOVE Ratings Summary

MOVE Quant Ranking